Game Changer: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). Journal Article


Author: Lake, E
Article Title: Game Changer: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
Abstract: No abstract available
Journal Title: Journal of the American Academy of Dermatology
ISSN: 1097-6787; 0190-9622
Publisher: Mosby, Inc  
Date Published: 2018
LUC Authors
  1. Eden Lake
    11 Lake